US Allergy Drugs Market to Exceed $14.7 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a US report on Allergy Drugs market. The US market for allergy drugs is projected to exceed $14.7 billion by the year 2015. This is primarily driven by a continued rise in the number of patients suffering from allergies, including children; an aging population; and availability of a wide range of medicines for adults, children and infants over-the-counter in pharmacies and drugs stores.

Allergy Drugs: A US Market Report

Allergy is a widespread and growing health problem in almost all countries worldwide, and shows no signs that the number of sufferers would decrease or even stabilize in the coming years. It ranks among the most major chronic diseases in the US, affecting daily life of millions of Americans. Factors causing allergies could be environmental or genetic, though cosmetics, jewelry and other substances also can cause allergic reactions. The most common environmental allergens include dust, pollen, mold, pet dander and insect bites, and well as certain foods and drugs.

Claritin/Clarinex of Schering-Plough and Zyrtec of McNeil Consumer Healthcare are the leading, most prescribed allergy drugs in the US, as stated by the new market research report on allergy drugs. Antihistamines represent the most widely prescribed anti-allergy products, followed by corticosteroids. The market for antihistamine drugs is particularly strong owing to the increased levels of effectiveness provided by these medicines when used in combination with a decongestant, as well as the non-sedating quality of antihistamines.

While sales of allergy drugs are growing, the market is also simultaneously witnessing demand increase for alternative medication, as more and more people are showing preference for alternative therapies for the treatment of their allergies. Though, complementary therapies are usually less effective in comparison to conventional medication, certain compounds show beneficial effects in relieving symptoms of allergic rhinitis.

Key players profiled in the report include Collegium Pharmaceutical, Inc., McNeil Consumer Healthcare, Meda Pharmaceuticals, Inc., Novartis Consumer Healthcare Inc., Schering-Plough Corporation, Sepracor, Inc., Vicks, among others.

The report titled "Allergy Drugs: A US Market Report" announced by Global Industry Analysts, Inc., provides a review of market, market drivers, prevalence data, product introductions/ approvals, and recent industry activity. The study analyzes market data and analytics in terms of value sales for product segments, including - Prescription Antihistamines, Prescription Corticosteroids, and OTC Allergy Drugs.

For more details about this market research report, please visit -

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Web Site


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website